Researchers use CRISPR to develop a Ewing sarcoma stem cell model – Medical Xpress

May 11, 2017 Credit: CNIO

A team from the Spanish National Cancer Research Centre (CNIO) has optimized a system capable of generating a cellular model of Ewing sarcoma. The technique, based on CRISPR and described in the pages of Stem Cell Reports, makes it possible to generate cellular models to analyse the mechanisms underlying the origin and progression of this and other diseases, as well as the search for new treatments.

CRISPR, the famous genomic editing technique, not only serves to cure diseases, it can also recreate diseases in cellular models to study the molecular events that give rise to them. These models are crucial to find new diagnostic and therapeutic pathways. In a paper published in the journal Stem Cell Reports, the authors present a significant technological development capable of recreating Ewing sarcoma in adult and embryonic human stem cells.

"The idea is to have a system that enables us to generate a model that is as accurate as possible to what is happening in a tumour," said Sandra Rodrguez Perales from the Molecular Cytogenetics and Genomic Engineering Unit and leader of the research project.

With a model that reproduces the origins of the disease, it will be possible to analyse the underlying mechanisms and molecular bases of each pathology. In the case of Ewing sarcoma, the trigger of the disease is a translocation between chromosomes 11 and 22, which gives rise to the fusion of two genes, resulting in a new oncogene.

The authors had already used CRISPR to induce this alteration and generate a model of the disease, but they encountered a low level of efficacy and other methodological difficulties in applying the technique to human stem cells. "When we were working with cell lines, everything went smoothly, but when we applied it to stem cells, we came across a lot of problems," explains Ral Torres Ruiz, co-author of the paper.

To improve the results and to refine the technique, they compared three strategies to generate this translocation in the most efficient way possible using CRISPR. After several experiments, they noted that by combining the use of a sgRNA-Cas9 ribonucleoprotein complex generated in the laboratory (in place of a plasmid expression) and of a DNA "staple"a short sequence that connects the ends of two chromosomes that breaks the CRISPR system and therefore facilitates translocationthe success rate increased by up to seven times. This suggests that the researchers have found "a solid tool to induce targeted translocations."

All the improvements implemented during the study have resulted in a model of induced pluripotent stem cells (iPSC) with enormous potential from a scientific point of view. They constitute an ideal cellular model for the study of the development of various pathologies, among them the initial stages of oncogenic processes. All this will allow the study of the mechanistic bases of pathologies such as Ewing sarcoma.

In addition, it is also "a valid approximation for other pathologies," said Rodrguez Perales. "This strategy will facilitate the creation of cancer models from human stem cells and accurate genome editing to search for new drugs or cellular therapies, thus accelerating the advance from the laboratory to the clinic."

Explore further: Tumor chromosomal translocations reproduced for the first time in human cells

More information: Raul Torres-Ruiz et al, Efficient Recreation of t(11;22)EWSR1-FLI1 +in Human Stem Cells UsingCRISPR/Cas9, Stem Cell Reports (2017). DOI: 10.1016/j.stemcr.2017.04.014

Journal reference: Stem Cell Reports

Provided by: Centro Nacional de Investigaciones Oncolgicas (CNIO)

Scientists from the Spanish National Cancer Research Centre (CNIO) and the Spanish National Cardiovascular Research Centre (CNIC) have been able to reproduce, for the first time in human cells, chromosomal translocations ...

Mount Sinai researchers have created a novel model that shows the step-by-step progression from normal blood cells to leukemia and its precursor diseases, creating replicas of the stages of the disease to test the efficacy ...

Scientists have demonstrated how a mutation in a specific protein in stem cells causes an incurable premature aging disease called dyskeratosis congenita, and were able to introduce the mutation into cultured human cells ...

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in mice. The unexpected findings, ...

Ewing sarcoma is a cancer of bone or its surrounding soft tissue that primarily affects children and young adults. A hallmark of Ewing sarcoma is a translocation event that results in the fusion of an RNA binding protein, ...

A new Northwestern Medicine study, published in Genes and Development, has identified two DNA elements crucial to the activation of a set of genes that drive the early development of embryos, and which also play an important ...

Many cancer patients, especially those who've undergone breast cancer treatment, experience painful, swollen limbs, a condition called lymphedema.

Among today's most promising weapons against cancer is the use of therapies that direct the immune system against a tumor. One approach - immune checkpoint blockade - is designed to circumvent the "off switches" that prevent ...

Reported in Nature today, one of the largest sets of high quality human induced pluripotent stem cell lines from healthy individuals has been produced by a consortium involving the Wellcome Trust Sanger Institute. Comprehensively ...

Lung adenocarcinoma, an aggressive form of cancer that accounts for about 40 percent of U.S. lung cancer cases, is believed to arise from benign tumors known as adenomas.

UT Health San Antonio researchers discovered epigenetic changes that contribute to one-fifth of cases of acute myeloid leukemia (AML), an aggressive cancer that arises out of the blood-forming cells in bone marrow.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read the rest here:
Researchers use CRISPR to develop a Ewing sarcoma stem cell model - Medical Xpress